Blood Cancer Institute Directors & Members

Working in a highly collaborative manner across Montefiore Einstein Comprehensive Cancer Center, global leaders in blood cancer research and care are driving advances in better understanding, preventing, and treating MDS, AML, and myriad other blood cancers. Much of the power of the Blood Cancer Institute derives from the multidisciplinary perspectives, insights, and tools that the members provide.

Blood Cancer Institute Directors

Under the leadership of Marina Konopleva, MD, PhD, Ulrich Steidl, MD, PhD, and Amit Verma, MD, the Blood Cancer Institute is making great strides in expanding treatment options for people with blood cancers.  

Marina Konopleva, MD, PhD

Director, Leukemia Program

Ulrich G. Steidl, MD, PhD

Deputy Director, and Associate Director for Basic Science, Montefiore Einstein Comprehensive Cancer Center

Amit K. Verma, MD

Associate Director, Translational Science, Montefiore Einstein Comprehensive Cancer Center

Blood Cancer Institute Assistant Directors

BCI has appointed four Associate Directors to help shape the work and future BCI efforts in the area of basic and translational science. They will assist BCI leadership in fostering research collaborations, mentorship of junior faculty, educational activities, funding initiatives, and translation into novel clinical trials for our patients.

Teresa V. Bowman, PhD

Assistant Director of Basic Science

Kira Gritsman, MD, PhD

Assistant Director of Correlative Clinical Research

Aditi Shastri, MD

Assistant Director of Translational Research

Britta Will, Ph.D.

Assistant Director of Preclinical Modeling

Blood Cancer Institute Members

The more than 20 members of the Blood Cancer Institute help shape and drive basic and translational research in blood cancers.